Hirudin and other thrombin inhibitors experimental results and potential clinical applications
- 30 September 1991
- journal article
- review article
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 1 (6), 261-267
- https://doi.org/10.1016/1050-1738(91)90032-a
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparationJournal of the American College of Cardiology, 1990
- The Structure of a Complex of Recombinant Hirudin and Human α-ThrombinScience, 1990
- Dynamic monitoring of platelet deposition on severely damaged vessel wall in flowing blood. Effects of different stenoses on thrombus growth.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Contribution of the N-terminal region of hirudin to its interaction with thrombinBiochemistry, 1989
- Mechanisms of arterial thrombosis in nonparallel streamlines: platelet thrombi grow on the apex of stenotic severely injured vessel wall. Experimental study in the pig model.Journal of Clinical Investigation, 1989
- Studies on antithrombotic effects of recombinant hirudinThrombosis Research, 1989
- Importance of adequate heparin dosage in arterial angioplasty in a porcine model.Circulation, 1988
- Insights into the pathogenesis of acute ischemic syndromes.Circulation, 1988
- Thrombin‐Cellular InteractionsAnnals of the New York Academy of Sciences, 1986
- Selective inhibition of thrombin by (2R,4R)-4-methyl-1-[N2-[1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-L-arginyl]-2-piperidinecarboxylic acidBiochemistry, 1984